SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-22-024854
Filing Date
2022-09-13
Accepted
2022-09-13 17:19:35
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 pointbiopharma-424b5.htm 424B5 478955
2 logoa.jpg GRAPHIC 59499
3 point-logoxcoloura.jpg GRAPHIC 17537
  Complete submission text file 0001628280-22-024854.txt   586189
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-265981 | Film No.: 221241531
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences